Fact Sheet

superDimension is a privately-held medical device company that develops and markets minimally-invasive pulmonology devices that enable the diagnosis and potentially the treatment of distal lung disease.
The company was founded in Tel Aviv, Israel by Pinhas Gilboa, and is headquartered in Minneapolis, Minn., with other offices located in Dusseldorf, Germany. The company has more than 100 employees worldwide.
superDimension’s mission is to be the world's leader in the diagnosis and treatment of distal lung disease.
The company’s product line addresses a total available market of more than 8 million potential patients in the United States alone.
superDimension’s inReach^TM System extends beyond the capabilities of the bronchoscope to distant, previously inaccessible regions of the lungs not accessible through traditional bronchoscopy, enabling physicians to locate small lung lesions for diagnostic testing and potential treatment.
superDimension has conducted successful clinical trials in the biopsy of peripheral lung lesions in Europe and Israel since 2003. High success rates were achieved consistently with patients for whom traditional bronchoscopy had either failed or had not even been attempted.
superDimension obtained its CE Mark in 2002 and has 510(k) clearance from the FDA.
superDimension holds fourteen granted U.S. patents. In 2004, the company was selected by MIT's Technology Review magazine as holding one of the world's five most outstanding patents; it was the only healthcare-related company among the five distinguished.
superDimension has over a dozen published clinical papers, written by authorities from the world’s leading interventional pulmonology institutions.